NeuroOne Medical Technologies Corporation – Filings and Transcripts

NASDAQ: NMTC
Share price (10/20/26): $0.98
Market cap (10/20/26): $8.958 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/26 Q3

ended 03/31/26 Q2 2026 – amended

ended 03/31/26 Q2

ended 12/31/25 Q1

ended 09/30/25 FY 2025 – amended

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Registration of securities for employees

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Ownership Filter

Wambeke David J.

Volker Christopher

Christianson Mark

News Filter

Reports Preliminary Fiscal Q4 Product Revenue Growth of 38.4%; Secures Record $4.5 Million Purchase Order

Announces Successful Robotic-Assisted Drug Delivery Using Next-Generation StereoCED™ Platform

NeuroOne® Reports Fiscal Q3 2026 Financial Results, Revenues Increase 16% YoY to $2.0 Million; Gross Margins Expand to 59.9%

Other Events, Financial Statements or Exhibits

NeuroOne® Medical Technologies Announces Restatement of Financial Results for Quarter Ending March 31, 2026

Proxies Filter

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Additional info about upcoming vote

Definitive proxy

Other Filter

Conflict Minerals disclosure

Conflict Minerals disclosure

Scanned paper annual report submission

Conflict Minerals disclosure

Conflict Minerals disclosure